These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22353525)

  • 21. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.
    Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of preoperative prognostic factors in patients with resectable invasive intraductal papillary mucinous carcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Surgery; 2020 Dec; 168(6):994-1002. PubMed ID: 32139141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraductal papillary-mucinous tumors of the pancreas.
    Kubosawa H; Uehara T; Watanabe Y; Urashima T; Matsubara H; Asano T; Ochiai T
    Hepatogastroenterology; 2004; 51(59):1489-94. PubMed ID: 15362784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas.
    Nakagohri T; Asano T; Kenmochi T; Urashima T; Ochiai T
    World J Surg; 2002 Sep; 26(9):1166-9. PubMed ID: 12045867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features and prognosis of intraductal papillary mucinous neoplasms of pancreas: analysis of 38 cases].
    Lou WH; Wang DS; Ji Y; Xu XF; Kuang TT; Ni XL; Wu WC; Jin DY
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):947-50. PubMed ID: 16759531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.
    Sadakari Y; Ohuchida K; Nakata K; Ohtsuka T; Aishima S; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Surgery; 2010 Jun; 147(6):812-7. PubMed ID: 20060146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas.
    Sauvanet A; Gaujoux S; Blanc B; Couvelard A; Dokmak S; Vullierme MP; Ruszniewski P; Belghiti J; Lévy P
    Ann Surg; 2014 Aug; 260(2):364-71. PubMed ID: 24646561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection.
    Rodriguez JR; Salvia R; Crippa S; Warshaw AL; Bassi C; Falconi M; Thayer SP; Lauwers GY; Capelli P; Mino-Kenudson M; Razo O; McGrath D; Pederzoli P; Fernández-Del Castillo C
    Gastroenterology; 2007 Jul; 133(1):72-9; quiz 309-10. PubMed ID: 17631133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
    Jang JY; Kim SW; Lee SE; Yang SH; Lee KU; Lee YJ; Kim SC; Han DJ; Choi DW; Choi SH; Heo JS; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee HE; Kang GH; Lee JM
    Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
    Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
    Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.
    Worni M; Akushevich I; Gloor B; Scarborough J; Chino JP; Jacobs DO; Hahn SM; Clary BM; Pietrobon R; Shah A
    Ann Surg Oncol; 2012 Apr; 19(4):1316-23. PubMed ID: 22002799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
    Schmidt CM; White PB; Waters JA; Yiannoutsos CT; Cummings OW; Baker M; Howard TJ; Zyromski NJ; Nakeeb A; DeWitt JM; Akisik FM; Sherman S; Pitt HA; Lillemoe KD
    Ann Surg; 2007 Oct; 246(4):644-51; discussion 651-4. PubMed ID: 17893501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
    Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
    J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.